SUCAMPO PHARMACEUTICALS INC's ticker is and the CUSIP is 864909AA4. A total of 4 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 2.8%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 12,000,000 | $14,670,000 | 8.68% |
| Worth Venture Partners, LLC | 1,878,000 | $2,292,000 | 2.54% |
| GABELLI FUNDS LLC | 2,250,000 | $2,732,000 | 0.02% |
| UBS Group AG | 3,500,000 | $4,250,000 | 0.00% |